Role of Zika virus prM protein in viral pathogenicity and use in vaccine development

36Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

Abstract

Recent Zika virus (ZIKV) epidemics necessitate the urgent development of effective drugs and vaccines, which can be accelerated by an enhanced understanding of ZIKV biology. One of the ZIKV structural proteins, precursor membrane (prM), plays an important role in the assembly of mature virions through cleavage of prM into M protein. Recent studies have suggested that prM protein might be implicated in the neurovirulence of ZIKV. Most vaccines targeting ZIKV include prM as the immunogen. Here, we review progress in our understanding of ZIKV prM protein and its application in ZIKV vaccine development.

Cite

CITATION STYLE

APA

Nambala, P., & Su, W. C. (2018, August 2). Role of Zika virus prM protein in viral pathogenicity and use in vaccine development. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2018.01797

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free